文献詳細
特集 泌尿器腫瘍における放射線治療―変革期を迎えた令和のトレンド
〈前立腺癌〉
文献概要
▶ポイント
・体幹部定位放射線治療(SBRT)は,1回大線量を病巣に集中照射して照射回数4〜5回と,従来に比べて大幅に少ない回数で治療が完遂する治療法である.
・第Ⅲ相試験や第Ⅱ相試験のpooled analysisで,他治療に遜色ない治療成績と安全性が報告されている.
・連日照射は必須ではなく,患者の体の状態や都合に応じて,週1〜3回照射も可能である.
・体幹部定位放射線治療(SBRT)は,1回大線量を病巣に集中照射して照射回数4〜5回と,従来に比べて大幅に少ない回数で治療が完遂する治療法である.
・第Ⅲ相試験や第Ⅱ相試験のpooled analysisで,他治療に遜色ない治療成績と安全性が報告されている.
・連日照射は必須ではなく,患者の体の状態や都合に応じて,週1〜3回照射も可能である.
参考文献
1) Brenner DJ, et al : Fractionation and Protraction for Radiotherapy of Prostate Carcinoma. Int J Radiat Oncol Biol Phys 43 : 1095-1101, 1999
2) Malouff TD, et al : Current Use of Stereotactic Body Radiation Therapy for Low and Intermediate Risk Prostate Cancer : A National Cancer Database Analysis. Prostate Cancer Prostatic Dis 23 : 349-355, 2020
3) National Comprehensive Cancer Network. NCCN Guidelines Version 3.2022 Prostate Cancer 2022
4) Wolf F, et al : Ultrahypofractionation of Localized Prostate Cancer : Statement from the DEGRO Working Group Prostate Cancer. Strahlenther Onkol 197 : 89-96, 2021
5) Jackson WC, et al : Stereotactic Body Radiation Therapy for Localized Prostate Cancer : A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated on Prospective Studies. Int J Radiat Oncol Biol Phys 104 : 778-789, 2019
6) King CR, et al : Long-Term Outcomes from a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 82 : 877-882, 2012
7) Alayed Y, et al : Accelerating Prostate Stereotactic Ablative Body Radiotherapy : Efficacy and Toxicity of a Randomized Phase II Study of 11 versus 29 Days Overall Treatment Time (PATRIOT). Radiother Oncol 149 : 8-13, 2020
8) Widmark A, et al : Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer : 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial. Lancet 394 : 385-395, 2019
9) Kishan AU, et al : Long-Term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open 2 : e188006, 2019
10) van Dams R, et al : Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium : Analysis of 344 Prospectively Treated Patients. Int J Radiat Oncol Biol Phys 110 : 731-737, 2021
11) Brand DH, et al : Intensity-Modulated Fractionated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B) : Acute Toxicity Findings from an International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial. Lancet Oncol 20 : 1531-1543, 2019
掲載誌情報